메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
대한안과학회 Korean Journal of Ophthalmology Korean Journal of Ophthalmology 제28권 제3호
발행연도
2014.1
수록면
226 - 233 (8page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose: To evaluate the usefulness of the interferon-gamma release assay (IGRA) for diagnosing tuberculosis(TB)-related uveitis (TRU). Methods: Records from 181 patients with ocular signs and symptoms suggestive of TRU and intraocular inflammationof unknown etiology were reviewed. All subjects underwent clinical and laboratory testing, includingIGRA, to rule out presence of underlying disease. A diagnosis of presumed TRU was made based on an internist’sTB diagnosis and a patient’s response to anti-TB therapy. Sensitivity, specificity, and positive predictivevalues of IGRA for TRU diagnosis were calculated. Clinical characteristics were compared between patientswith positive and negative IGRA results. Results: The sensitivity and specificity of IGRA for TRU were 100% and 72.0%, respectively. Mean age, percentageof patients with retinal vasculitis, and the anatomic type of uveitis were significantly different betweenpatients with positive and negative IGRA results (all p ≤ 0.001). Positive IGRA rates and false-positive rateswere significantly different between age and anatomic type groups (both p = 0.001). The positive predictivevalue of the IGRA among patients with intraocular inflammation was high (70%) when all of younger age (≤40years), posterior uveitis, and retinal vasculitis were present. Conclusions: The IGRA is useful for diagnosing TRU in the Korean population, especially when it is used as ascreening test. Clinical characteristics, including younger age (≤40 years), posterior uveitis, and retinal vasculitisin IGRA-positive patients, increase the likelihood of the patient having TRU.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0